IMUX raises €58.5M Growth round

3 June 2025· Mannheim, Germany· manufacturing, energy, robotics, b2b, software_hardware

The funding is intended to fund its clinical trials and operations and for other general corporate purposes.

Investors

LeadBVF Partners
Also participating
Janus Henderson InvestorsAberdeen InvestmentsCoastlands CapitalAdage Capital Partners LP

About IMUX

Stage
Growth
Headquarters
Mannheim, Germany
Founded
2020
Team Size
6–20
Sectors
manufacturingenergyroboticsb2bsoftware_hardware

Source: https://www.imux.com/immunic-inc-announces-closing-of-oversubscribed-65-million-underwritten-public-offering/